Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

Clinical trial NCT02603328 · COMPLETED

Trial details

NCT number: NCT02603328
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cerebral Cavernous Malformation

Start date: 2018-07-17
Primary completion: 2024-07-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.